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1. Introduction 
Since its commercial advent in 1985, transcranial magnetic stimulation (TMS), a technique 
for stimulating neurons in the cerebral cortex through the scalp, safely and with minimal 
discomfort, has captured the imaginations of scientists, clinicians and lay observers 
[Wassermann et al, 2012]. Initially a laboratory tool for neurophysiologists studying the 
human motor system, TMS now has a growing list of applications in clinical and basic 
neuroscience. At cortical level, the abnormal amplitudes of the motor evoked potentials 
(MEP) may be due to the damage of the motoneurons themselves; as well as to their reduced 
capacity for repetitive excitation; deficit of the intracortical synaptic transmission (transfer); 
activation of motoneuron inhibitors, etc. At subcortical level the causes may be 
demyelinization, remyelinization, activation of the long-latent corticofugal fibres, axonal 
damage, etc. [Komori et al, 1993].  
The human brain possesses a remarkable ability to adapt in response to changing 
anatomical (e.g., aging) or environmental modifications. This form of neuroplasticity is 
important at all stages of life but is critical in neurological disorders such as amblyopia and 
stroke [Sharma, 2012]. When MEP are obtained in the acute phase of stroke, the functional 
recovery of the motor deficit, as a rule, is to occur [Nowak et al, 2010; Dimyan, 2010]. The 
initially registered normal MEP amplitudes have a predictive value in the view of the long-
term functional outcome [Stinear, 2010; Dimyan et al, 2010;].  
The TMS approach was also used in the investigation of patients with lacunar strokes. The 
central motor conduction time (CMCT) and the threshold intensities for eliciting MEPs in 
the relaxed muscles were significantly increased on the affected side. MEP amplitude 
abnormalities were related to pyramidal signs (though they could be observed also in a 
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patient without any motor impairment) and occurred independently of a specific clinical 
picture or a radiologically confirmed lacunar lesion [Abbruzzese et al, 1991; Hufnagel et al, 
1990]. Earlier studies have shown that during the acute phase of the minor ischaemic stroke 
(MIS), MEP amplitudes can be registered in all investigated patients [Hadjipetrova et al, 
1993]. To note, the increases in the latency of the M-response and CMCT have prognostic 
significance for early assessment of the outcome of ischaemic stroke [Stulin et al, 2003]. 
Earlier studies by Ferbert and collaborators [1992] have indicated that the MEP amplitudes 
are a more sensitive marker for the sublclinical damage of the pyramidal tract than CMCT. 
A significant correlation has also been reported among the recovery of muscle strength and 
the amplitude of MEP [Palliyath, 2000]. 
The aim of this study was to perform a post-hoc analysis of one-year follow-up data from 40 
patients with MIS and to: (i) investigate the central motor conduction time (CMCT) and the 
amplitude of the motor evoked potential (MEP) during the acute phase of MIS; (ii) provide 
evidence for a subclinical damage of the pyramidal tract; and (iii) model and predict the 
outcome measures at month 12 after MIS as based on earlier changes in the acute phase. 
2. Methods 
2.1. Patient selection, diagnosis, data collection, and main characteristics 
The Plovdiv project included hospital-based incident cases of patients with minor ischaemic 
stroke (MIS) that were followed for 12 months to determine the estimates of central motor 
conduction time (CMCT) and amplitudes of motor evoked potential (MEP) and their 
changes and correlations over time.  
This is a post-hoc analysis and modelling study. The patient population has been described in 
more detail earlier [Atanassova, 1998; Atanasova & Vukov, 1998; Atanassova, Voukov & 
Tchalakova, 2002; Atanassova, Chalakova & Dimitrov, 2008a]. In particular, patients with 
cerebrovascular disease had been hospitalized in the Clinic of Cerebrovascular Diseases 
(Plovdiv Healthcare Region) and 56 consecutive patients with MIS were subjected to 
screening. All screened, eligible patients with MIS as an initial index event who provided a 
written, informed consent in accordance with the Declaration of Helsinki guidelines at 
discharge were immediately enrolled. During the lag interval from the index event until 
discharge (i.e., during the hospital stay), no vascular events were observed among the 56 
screened eligible patients. Of these eligible patients, 54 patients (96.4%) provided written, 
informed consent and were included in the current follow-up study. The other 2 eligible 
patients did not provide informed consent at discharge and were not enrolled (Figure 1). 
Further, till month 12, a total of 14 patients were excluded or lost to follow-up and could not 
provide data on the outcome, therefore, 40 patients were subjected to statistical analyses and 
modelling in this study. The inclusion criteria were: patients with first MIS, age > 40 years and 
residence in Plovdiv for at least three months before identification and enrolment [Atanassova, 
Chalakova & Dimitrov, 2008a]. All evaluations were performed at Medical University Hospital 
of Plovdiv, Bulgaria. The University Ethical Committee approved the study protocol. 
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Figure 1. CONSORT flow-chart of study screening, enrolment and analysis. 
Data were collected by instructed physicians and clinical (physical and neurological) 
examinations were conducted by study neurologists [Atanassova, Chalakova & Dimitrov, 
2008a]. The assessments covered: hypertension, diabetes, dyslipidaemia, peripheral vascular 
disease, cardiac conditions, cigarette smoking, educational background, etc. 
Initial stroke severity was assessed using the modified Rankin Scale [Bamford et al, 1990]. 
MIS diagnostic evaluations included CT or MRI of the brain and ultrasound evaluation 
and/or trans-thoracic or trans-oesophageal echocardiogram, as appropriate. A panel of 
stroke neurologists assessed every CV events subtype using standard diagnostic criteria and 
all available information for each patient. For this study, MIS was defined as a minor stroke 
if the score on the modified Rankin Scale was 1 at the first evaluation, or if the score was 0 or 
1 at one-month follow-up (i.e., no symptoms, or minor symptoms that did not interfere with 
normal lifestyle) [Atanassova, 1998; Atanasova & Vukov, 1998; Atanassova, Voukov & 
Tchalakova, 2002]. In particular, acute onset was observed in 11 patients (20.4%). Extra-
cranial ultrasound findings were recorded in 11 patients (20.4%). The main characteristics of 
the initial study cohort were as follows: 37 men (68.5%) and 17 women (31.5%), with male 
predominance in CV events (n=8 men) but with similar ages of 61.1±12.6 years in patients 
with CVE versus 62.2±9.2 years in patients without CVE (p>0.05). The mean follow-up time 
was 11.1±2.4 months with mean time to CV events of 5.8±2.7 months. For the purpose of this 
study, all MIS patients with subsequent stroke (n=8) as defined above, were excluded from 
the analysis. 
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2.1.1. Assessment of outcomes 
The main outcome was defined as estimates of central motor conduction time (CMCT) and 
amplitudes of motor evoked potential (MEP) at month 12. We performed transcranial 
magnetic stimulation by MAGSTIM 200 after MIS (day 7 in month 1, month 3, and month 
12) on the motor cerebral cortex bilaterally and on C7 with consecutive conduction of MEPs 
by surface electrodes from isometrically slightly contracted muscle abductor policis brevis. All 
measurements were taken as related to the symptomatic and asymptomatic hemispheres 
and differences between them were also analysed (Table 1). Normal values from 30 healthy 
subjects were also obtained for reference purposes. 
 
Outcome parameters in MIS 





hemisphere (n=40 cases*) 
p-value 
Central motor conduction time 
(CMCT) [ms] 
   
at Month 1 (day 7) 9.147 ± 1.862 7.550 ± 1.465 <0.05 
at Month 3 8.038 ± 1.392 7.135 ± 1.052 <0.05 
at Month 12 10.720 ± 1.831 8.550 ± 1.497 <0.05 
Amplitude of motor evoked 
potential (MEP) [mV] 
   
at Month 1 (day 7) 6.083 ± 1.882 8.963 ± 1.925 <0.05 
at Month 3 7.293 ± 1.876 10.350 ± 2.160 <0.05 
at Month 12 7.290 ± 1.757 9.880 ± 1.986 <0.05 
Notes: *Number of cases (measurements) in the MIS patients with TMS values; Data are mean ± standard deviation; 
°Difference at p<0.05 is considered statistically significant. Abbreviations: MIS, minor ischaemic stroke. 
Table 1. Main outcomes of TMS in 40 MIS patients, followed prospectively for 12 months, as measured 
according to the existing symptomatics (symptomatic or asymptomatic hemisphere) 
As secondary outcomes, the changes from month 1 onwards, as well as the correlations 
between the estimates, were also analysed. The role of the symptomatics (i.e., measures for 
symptomatic or asymptomatic hemisphere) as a predictor of the main outcome estimates at 
month 12, was also investigated. The presence/absence of non-fatal or fatal CV event after 
MIS was considered for the diagnosis of the MIS patients with a subsequent stroke, who 
were to be excluded from the analyses. Thus, two2 sub-categories for each secondary 
outcome were established as events classification: (i) non-fatal CVE; (ii) fatal CVE. Strict 
evaluations were conducted in 4 visits (at baseline, at month 1, month 3 and month 12), with 
telephone interview every other month, till month 12. Every evaluation was carried-out by 
contact with the patient, family member, or caregiver. Information was collected by somatic 
examination, inter-current symptoms, illness or hospitalization. The in-person visits were 
conducted at our clinic and included measuring vital signs, physical and neurological 
examination. A registry reporting system was used to identify study participants who 
experienced nonfatal or fatal vascular events, related hospitalization or death (vascular or 
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nonvascular death). All records were reviewed for all outcome events, including death, and 
have been maintained. All outcome events were reviewed by a neurology specialist. Non-
fatal strokes were validated by a study neurologist, and all deaths were to be validated, as 
well. Deaths were to be classified using death certificates and medical records.  
Death as an eventual fatal outcome was defined as to be considered as due to stroke if 
there was clear documentation of a stroke from the death certificate or hospital records; 
deaths that would have occurred more than 30 days after the initial accident (i.e., 
secondary CV event) had to be considered related to the event on the grounds of a clinical 
judgment that relied on a clearly documented relationship to the stroke or its 
complications to the point of death in the medical records. Following the ascertainment 
procedures, all above mentioned death notifications, certificates, and autopsy protocols 
for all cases of death had to be collected and reviewed individually, especially for patients 
who died outside the hospital. In cases in which it was difficult to determine whether 
death was due to stroke, consensus was reached after discussion using the best available 
information.  
2.2. Sample size, data elaboration and statistical analyses 
2.2.1. Sample size estimation  
The sample size of the initial follow-up cohort of 56 patients to be screened was calculated 
on the basis of the expected number of CV events, as described previously in more detail 
[Atanassova, Chalakova & Dimitrov, 2008a]. Having assumed a theoretical distribution 
from 0 to 50% for the non-events and based on the 3-year cumulative incidence of 24.5% for 
cerebrovascular events in MIS patients [Atanassova, Chalakova & Dimitrov, 2008b], 8.16% 
of CV events were to be expected in 12 months. Thus, it had been estimated that to give the 
study >95% power to detect such minimum event rate as statistically significant at p<0.05, 51 
patients had to be included and analysed. A preliminary estimate of the prevalence of MIS 
patients that would satisfy the inclusion/exclusion criteria from all those referred to the 
Clinic of Cerebrovascular Diseases yearly had indicated that 56 patients with MIS had to be 
identified throughout a screening period of about 12 months (estimated maximum 10% 
drop-out). Given the pilot nature of the probabilistic modelling of the estimates and 
derivation of predictions at month 12 for both studied parameters (CMCT and MEP), no 
further sample size calculations were performed. 
2.2.2. Data elaboration and statistical analyses  
The main endpoint for both the central motor conduction time and amplitudes of motor 
evoked potentials was considered as an estimated mean (± standard deviation, S.D.) at 
month 12 (Table 1). Two other interim measures of the outcomes were also taken (at month 
1 and month 3). A test for normality of distributions (Shapiro-Wilk test) was applied. The 
differences were analysed by two-tailed paired parametric (t-test, etc.) or non-parametric 
(Wilcoxon signed-rank) tests at p<0.05, as appropriate, as well as repeated-measures 
Computational Intelligence in Electromyography Analysis –  
A Perspective on Current Applications and Future Challenges 42 
ANOVA (general linear models) in the view of the symptomatic and asymptomatic 
hemispheres (Figure 2 & Figure 3). As appropriate, parametric and non-parametric 
correlations between CMCT and MEP at various times were also performed.  
Parametric regression modelling was used to analyse the data and develop models to 
predict the outcomes at month 12 (Table 2). The significant relationships were later explored 
and confirmed by probabilistic artificial neural network (ANN) modelling, irrespectively of 
usual statistical constraints (Figures 4 & Figure 5). The stopping rule of learning was 
assumed when a state of maximum overall correctness of prediction with minimum average 
learning error was reached [Sarle, 1997]. The p-values less than 0.05 were considered 
statistically significant. The specialised software packages for statistical (SPSS ver.18) and 
probabilistic modelling (EasyNN ver.6.0i) were used. 
3. Results 
3.1. Descriptive statistics and basic comparisons 
The recruited patient cohort consisted of 54 patients (37 males and 17 females), mean age 
of 62 years (SD 9.6). The neurological deficit by the Rankin’s scale was assess at mRs=1 (37 
patients), mRs=2 (16 patients) and mRs=3 (1 patient). Most frequent minor ischaemic 
strokes occurred in the left carotid system (53.7%), right carotid system (31.4%), both 
systems (9.3%) as well as in the vertebrobasilar system (5.6%). Most frequently observed 
are the syndromes of the middle cerebral artery (hemiparesis and involvement of VII and 
XII cranial nerves), aphasias after a damage of the dominant hemisphere, upper 
monoparesis and motor aphasia, etc. In particular, during the mean follow-up of 11.1±2.4 
months, 8 secondary CV events (14.8%) were observed only in males within a mean 
period of 5.8±2.7 months. No difference in the age of patients with CV event (61.1±12.6 
years) vs. those without (62.1±9.6 years) was found (p>0.05). The one-year risk for CVE 
was ≈15% (95%CI 7.1÷27.7%). The other main demographic and clinical parameters of the 
initial cohort of 54 patients were reported in a more detail earlier [Atanassova, Chalakova 
& Dimitrov, 2008a].  
The main results are summarized in Table 1. Although the distributions of CMCT at month 
12 in the asymptomatic hemisphere and MEP at month 1 in the symptomatic one were 
slightly skewed, two tendencies could be clearly observed. While there is clearly a difference 
in the TMS measures according to the existing symptomatics (i.e., symptomatic or 
asymptomatic hemisphere), the first one is an increase of CMCT over time with higher 
values in the symptomatic hemisphere, while the second one is again an increase of MEP 
over time, but the higher values this time are observed in the asymptomatic hemisphere 
(p<0.05). 
An interesting pattern is, however, that while CMCT first decreased from month 1 to 
month 3 and then increased (Figure 2), the MEP amplitude, in parallel but opposite, 
increased in month 3 and then decreased slightly in month 12 (Figure 3). In particular, 
there was a significant change over time (p<0.001) in CMCT and a multivariate, combined 
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effect of symptomatics and time (grand mean 8.523 ms, 95%CI 8.240-8.805, p=0.01). 
Notably, there was a statistically significant difference (adjusted for the baseline values at 
month 1) between the estimated marginal means of CMCT in the symptomatic (10.717 ms, 
95%CI 10.191-11.244) and asymptomatic (8.023 ms, 95%CI 8.023-9.077) hemispheres 
(Figure 2).  
There was a significant increase over time (p<0.001) in MEP amplitude, however, the 
multivariate, combined effect of symptomatics and time was not significant (grand mean 
8.310 mV, 95%CI 7.922-8.697, p=0.309). Certainly, there was a statistically significant 
difference between the estimated marginal means of MEP amplitude in the symptomatic 
(6.888 mV, 95%CI 6.340-7.437) and asymptomatic (9.731 mV, 95%CI 9.182-10.279) 







Figure 2. General linear modelling (repeated ANOVA) of CMCT changes from month 1 till month 12 
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Figure 3. General linear modelling (repeated ANOVA) of MEP amplitude changes from month 1 till 
month 12 
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Since these changes appeared to be parallel, we tested also the correlations between the 
measurements of TMS parameters at different months. In particular, there was a weak 
inverse, but significant correlations between CMCT and MEP (Spearman’s Rho=-0.45-0.46, 
p<0.05). Notably, the highest positive correlations were observed between CMCT at month 1 
and the following months (0.60-0.81, p<0.05) as well as between MEP at month 1 and the 
following months (0.78-0.87, p<0.05). The latter relationships provided the opportunity to 
model and predict the outcome at month 12 in the two TMS parameters. 
3.2. Statistical and probabilistic modelling of the outcome at 12 months 
The parametric regression modelling indicated that the CMCT outcome at month 12 can be 
predicted by the initial values at month 1 and whether or not these have been observed in 
the symptomatic or asymptomatic hemisphere (Fmodel=33.323, p<0.001, Table 2). The same 
is valid for the MEP amplitude outcome at month 12 (Fmodel=55.0.09, p<0.001, Table 2), 
although the role of the symptomatic as a predictor is with a marginal statistical significance 
(p=0.051). 
 




coefficient β* p-value 
Central motor conduction time at 
month 12 
CMCT at month 1 0.448 <0.001 
 Symptomatics -0.354 <0.001 
Amplitude of motor evoked 
potential at month 12 
Amplitude of MEP at 
month 1 
0.642 <0.001 
 Symptomatics 0.183 0.051 
Notes: *The predictor “symptomatics” is a categorical variable referring to the particular hemisphere, with two 
categories: symptomatic and asymptomatic. The constants, unstandardized coefficients β and their standards errors 
are available from the authors upon request. Abbreviations: TMS, transcranial magnetic stimulation; CMCT, central 
motor conduction time; MEP, motor evoked potential. 
Table 2. Parametric regression modelling to predict the TMS outcomes in 40 patients at month 12 
The above relationships were further investigated by a probabilistic modelling, employing 
artificial neural network (ANN) methodology, which has not the usual constrains of a 
parametric regression analyses (Figure 4 & Figure 5). The ANN for modelling and 
predicting CMCT at month 12 contained 9 nodes with 2 hidden layers, with two potential 
predictors: CMCT at month 1 and symptomatics (symptomatic or asymptomatic 
hemisphere) (Fig. 4). The structure for predicting the resulting outcome node was obtained 
when the average error decreased below the target value of 0.049. 
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Legend: Yellow circles (No.0–1) on the left indicate 2 input variables. The magenta circle (No.9) on the right is the 
output variable (outcome). The nodes of two hidden layers are grouped vertically and coloured in cyan: hidden layer 1 
(nodes No.2–5); hidden layer 2 (nodes No.6–8). ANN nodes description: Each node contains small bar charts indicating 
the basic functional parameters – net input (cyan bar), activation (magenta bar), bias (orange bar) and error (yellow 
bar). The hidden nodes are connected by lines, showing the type and strength of weights: the red and green lines 
indicate negative and positive weights, respectively. The thicker the line is, the heavier the weight. 
Figure 4. Artificial neural network trained with 40 patients to predict the CMCT outcome at month 12 
The modelling confirmed the finding from the parametric regression analysis (β=0.448, 
Table 2) for a slightly higher relative (predictive) importance of the CMCT at month 1 (0.301) 
than symptomatics (β=-0.354, relative importance = 0.290, not shown). 
The ANN for modelling and predicting MEP at month 12 contained 16 nodes with 2 
hidden layers, with two potential predictors: MEP at month 1 and symptomatics 
(symptomatic or asymptomatic hemisphere) (Fig. 5). The structure for predicting the 
resulting outcome node was obtained when the average error decrease below the target 
value of 0.049. The modelling confirmed the finding from the parametric regression 
analysis (β=0.642, Table 2) for a quite higher relative (predictive) importance of the MEP 
at month 1 (relative importance = 230.19) than symptomatics (β=0.183, relative importance 
= 62.06, not shown). 
Modelling of Transcranial Magnetic Stimulation in  





Legend: Yellow circles (No.0–1) on the left indicate 2 input variables. The magenta circle (No.16) on the right is the 
output variable (outcome). The nodes of two hidden layers are grouped vertically and coloured in cyan: hidden layer 1 
(nodes No.2–9); hidden layer 2 (nodes No.10–15). ANN nodes description: Each node contains small bar charts 
indicating the basic functional parameters – net input (cyan bar), activation (magenta bar), bias (orange bar) and error 
(yellow bar). The hidden nodes are connected by lines, showing the type and strength of weights: the red and green 




Figure 5. Artificial neural network trained with 40 patients to predict the MEP amplitude outcome at 
month 12 
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4. Discussion 
The one-year follow-up established a statistically significant dynamics in the MEP and 
CMCT outcomes. During the acute phase of the ischaemic stroke in the symptomatic 
hemisphere we found prolonged CMCT and reduced MEP amplitudes, similar to the 
findings by other authors [Segura et al, 1990]. When abnormal MEP amplitude is found, it is 
most likely the case of mainly functional disturbances of the pyramidal tract conduction, 
with a pathogenesis due to the acute disorder of cerebral circulation [Braune et al, 1996]. 
This may probably explain the prolonged latencies of MEP and reduced MEP amplitudes in 
the asymptomatic hemisphere. The decrease of the CMCT and the significant increase of the 
MEP amplitude (without reaching the normal values) at month 3, an according to 
Hadjipetrova et al [1993] – even at the 20-th day after the index event – could be explained 
with temporary functional compensation after MIS. 
According to some authors, the MEP amplitudes are a more sensitive marker than CMCT 
in the view of assessing the damage of the corticospinal tracts as a result of the brain 
ischaemia. After the acute phase, there might be a facillitation at cortical level, which 
could allow an increase in the MEP amplitude and may eventually explain the increases 
in the MEP amplitude at month 3 in our patients. In particular, the MEP amplitudes in 
the asymptomatic hemisphere achieve the normal values at month 3 and month 12. In 
the same time, it is known that the minor ischaemic strokes are most likely of lacunar 
type (i.e., “deep”, “subcortical”). The proportion of cortical clinical syndromes in our 
patients is relatively small and we could hypothesize that the abnormal MEP amplitudes 
might be present also in distant ischaemic lesion as it was shown earlier [Laloux et al, 
1991].  
At month 12, even in patients without neurological deficit and without recurrent 
cerebrovascular accidents, the CMCT is increased in both hemispheres. MEP amplitudes at 
month 12 are also reduced in the view of the normal values. These later changes are most 
likely due to the appearance of new asymptomatic structural changes of the corticospinal 
tracts during the progression of cerebrovascular disease. 
Last but not least, following the revealed correlations, we were also able to create 
predictive models for the outcomes at month 12. For both the CMCT and MEP 
amplitude, the regression models were based on the initial measures at month 1 and 
symptomatics (i.e., pertaining to symptomatic or asymptomatic hemisphere). We 
confirmed our results further by using such probabilistic approach as artificial neural 
networks modelling. ANN proved to be very useful in the current analysis as it allowed 
us to assess the role of potential predictors of CMCT and MEP at month 12 as continuous 
outcomes, without the possible constraints of parametric models (e.g., normal 
distribution of the outcome, etc.). To note, ANN had been successfully used in other 
medical fields [Mecocci, 2002; Grossi, 2011; Azarkhish et al, 2012; etc.] and, in neurology, 
in particular [Mecocci, 2002; Shanthi et al, 2009; for a recent overview see Atanassova & 
Dimitrov, 2011].  
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5. Conclusions 
This post-hoc analysis of one-year follow-up clinical trial data, obtained in 40 patients with 
minor ischaemic stroke, but without neurological deficit or recurrent cerebrovascular 
incidents, established a statistically significant dynamics in the MEP and CMCT outcomes 
after transcranial magnetic stimulation. During the acute phase of the ischaemic stroke (at day 
7 in month 1) we performed an initial measurement on the motor cerebral cortex bilaterally 
and on C7 with consecutive conduction of MEPs by surface electrodes from isometrically 
slightly contracted muscle abductor policis brevis and found prolonged CMCT and reduced 
MEP amplitudes in the symptomatic hemisphere. By following consecutive measurements at 
the end of month 3 and month 12, we revealed that the CMCT was increased in both 
hemispheres and MEP amplitudes were reduced, thus both remaining with abnormal values. 
At the interim measurement, CMCT were shorter but still abnormal in both hemispheres while 
the MEP amplitudes were lower, mostly in the symptomatic hemisphere. The changes at the 
end of the follow-up are most likely due to the appearance of new asymptomatic structural 
changes of the corticospinal tracts during the progression of the cerebrovascular disease. 
We observed a parallel dynamics and found correlations between CMCT and MEP at 
various times, preserving a significant asymmetry among the two hemisepheres. There was 
a statistically significant correlation between the initial values of CMCT and MEP and the 
outcome measurements at month 12. Thе parametric regression modelling indicated that 
CMCT outcomes at month 12 can be predicted by the initial values at month 1 and whether 
or not these have been observed in the symptomatic or asymptomatic hemisphere. The same 
is valid for the MEP amplitude outcomes at month 12, although the role of the symptomatics 
as a predictor is with a marginal statistical significance. The probabilistic ANN modelling 
confirmed the role of early CMCT (month 1) and hemisphere symptomatics in predicting 
the outcome at month 12. Given the dynamics of CMCT and MEP changes, we could 
postulate that cerebrovascular disease progression post-MIS may have most likely 
determined the subclinical damage of the pyramidal tract and its underlying mechanisms. 
6. Future directions 
Early MEP recordings in acute stroke patients provide valid prognostic information; they 
may become more useful for specific treatment decisions than presently available MRI 
surrogate parameters (Wohrle, 2004). The presence of MEP and disruption of the 
corticospinal tract on diffusion tensor tractography at the early stage of corona radiata 
infarct are indicative of a high probability of good and poor motor outcome at the chronic 
stage, respectively. We would suggest that further studies involving more parameters for 
TMS are warranted (Kwon, 2011).  
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